Cambridge COVID-19 Research Fund

The race is on to find a vaccine against the new COVID-19 coronavirus. Your support will make a difference.

Cambridge COVID-19 Research Fund

COVID-19 is having devastating effects across the world. Already a catastrophe, its escalation threatens every aspect of society and our future.

Combatting Coronavirus requires unprecedented speed, scope and ambition. Support from all quarters is crucial, to prevent and monitor its spread, to develop a vaccine, to improve diagnostic techniques and to discover the most effective treatment. 

Advancing our work is imperative. 

How you can help

Philanthropic donations of any size will have a real and immediate impact, enabling us to accelerate crucial research.

Making a gift to support COVID-19 research at Cambridge allows funds to be directed to where they are most needed.

About our research

Cambridge's extensive response to the novel Coronavirus (COVID-19) concentrates brilliant research minds on multiple aspects of the crisis: from mapping the virus’s genetic evolution as it spreads to advising industry on manufacturing-related challenges to advancing research rapidly to bring a possible vaccine to trial. 

Our epidemiologists, pathologists, immunologists, mathematicians and veterinary scientists are providing crucial knowledge and skills, and communicating to assist public understanding. From those working in the laboratories of the Cambridge Institute of Therapeutic Immunology & Infectious Disease, to those in the Department of Materials’ prototyping facilities, our scientists are focusing Cambridge expertise and innovation on the current crisis.

Reflecting the vast scale of the challenge, Cambridge is working together with academic colleagues across the globe, and with our partners at Cambridge University Hospitals and bodies such as Public Health England.

The breadth of Cambridge's research and expertise, combined with our close links to both the UK National Health Service and to industry, puts us in prime position to respond to the immediate tasks of understanding the virus and finding a vaccine, and to assess the long-term impact on society.

Making a gift to support COVID–19 research at Cambridge will allow us to direct funds to where they are most needed

You can support this research by making an online donation. If you would like to discuss further philanthropic opportunities, please contact Linda Hindmarsh.

Make a gift now

Make a gift now to support Cambridge COVID–19 Research Fund by credit or debit card, or set up a direct debit:

Give online

Or, find out about other ways to give.

Linda Hindmarsh

Senior Associate Director – School of Biological Sciences

+44 (0)1223 332288

Other ways to help

This opportunity is part of

covid-19 virus image
Cambridge is working hard to ensure that the full strength of the University’s research powers and resources are used in the global fight against COVID-19.

Related stories

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students receive an unrivalled education. Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.

Philanthropic impact story
The COVID-19 pandemic will have a “profound” impact on philanthropy through forging more active collaboration and ensuring more equitable responses, Bill Gates said in an interview with Badr Jafar (Churchill College, 1997), founding patron of the Centre for Strategic Philanthropy at Cambridge Judge Business School.
Philanthropic impact story
A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government.
Philanthropic impact story
The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19.
Philanthropic impact story
Since the University of Cambridge launched its COVID-19 research fund in March, more than 250 donors have given generously to help in the fight against the novel coronavirus.
Philanthropic impact story
COVID-19 has dramatically altered our students’ university experience, radically changing the Cambridge they know and exacerbating any underlying disadvantages.
Philanthropic impact story
Researchers say faster tests helped expedite access to life-saving treatments such as organ transplants – and might make all the difference later this year.